Dual-phase dual-energy CT in patients with lung cancer: assessment of the additional value of iodine quantification in lymph node therapy response

[1] Raz J(2007)Natural history of stage I non-small cell lung cancer: implications for early detection Chest 132 193-199

[2] Zell JA(2013)Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancer J Thorac Dis 5 S579-S592

[3] Ou SH(2010)RECIST revised: implications for radiologist. A review article on the modified RECIST guidelines Eur Radiol 20 1456-1467

[4] Gandara DR(2010)CT response assessment combining reduction in both size and arterial phase density correlates with time to progression in metastatic renal cancer patients treated with targeted therapies Cancer Biol Ther 9 15-19

[5] Anton-Culver H(2012)Mediastinal lymph node staging: from noninvasive to surgical AJR Am J Roentgenol 199 W54-W56

[6] Jablons M(2007)Additional value of PET-CT in staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT Eur Radiol 17 23-32

[7] Savas P(2003)Prognostic value of [18F]FDG-PET imaging in small cell lung cancer Eur J Nucl Med Mol Imaging 30 78-84

[8] Hughes B(2013)CT perfusion in oncologic imaging: a useful tool? AJR Am J Roentgenol 200 8-19

[9] Solomon B(2013)Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and antiangiogenic chemotherapy Eur Radiol 23 2127-2136

[10] Van Persijn van Meerten EL(2009)Basic principles and postprocessing techniques of dual-energy CT: illustrated by selected congenital abnormalities of the thorax J Thorac Imaging 24 152-159

[1] Raz J(2007)Natural history of stage I non-small cell lung cancer: implications for early detection Chest 132 193-199

[2] Zell JA(2013)Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancer J Thorac Dis 5 S579-S592

[3] Ou SH(2010)RECIST revised: implications for radiologist. A review article on the modified RECIST guidelines Eur Radiol 20 1456-1467

[4] Gandara DR(2010)CT response assessment combining reduction in both size and arterial phase density correlates with time to progression in metastatic renal cancer patients treated with targeted therapies Cancer Biol Ther 9 15-19

[5] Anton-Culver H(2012)Mediastinal lymph node staging: from noninvasive to surgical AJR Am J Roentgenol 199 W54-W56

[6] Jablons M(2007)Additional value of PET-CT in staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT Eur Radiol 17 23-32

[7] Savas P(2003)Prognostic value of [18F]FDG-PET imaging in small cell lung cancer Eur J Nucl Med Mol Imaging 30 78-84

[8] Hughes B(2013)CT perfusion in oncologic imaging: a useful tool? AJR Am J Roentgenol 200 8-19

[9] Solomon B(2013)Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and antiangiogenic chemotherapy Eur Radiol 23 2127-2136

[10] Van Persijn van Meerten EL(2009)Basic principles and postprocessing techniques of dual-energy CT: illustrated by selected congenital abnormalities of the thorax J Thorac Imaging 24 152-159